World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
77
Citations
16437
World Ranking
1376
National Ranking
601

Medicine

D-Index
78
Citations
16675
World Ranking
18205
National Ranking
9075

David N. Taylor publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David N. Taylor sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 190 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David N. Taylor D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David N. Taylor sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David N. Taylor is affiliated with Johns Hopkins University in the United States, focusing on research primarily within the field of medicine. Their work spans several subfields including public health, environmental and occupational health, pharmacology, infectious diseases, radiology, nuclear medicine and imaging, and cognitive neuroscience.

Their research covers a range of topics centered on musculoskeletal pain and rehabilitation, pain management and placebo effects, complementary and alternative medicine studies, clinical practice guidelines implementation, travel-related health issues, fibromyalgia and chronic fatigue syndrome research, as well as SARS-CoV-2 and COVID-19 research.

David N. Taylor has published in various scientific journals, with frequent contributions to:

  • The Journal of Alternative and Complementary Medicine
  • Journal of Chiropractic Medicine
  • Viruses
  • Journal of Travel Medicine
  • Journal of Manipulative and Physiological Therapeutics

Among their recent papers are the following:

  • "Low-Level Laser Light Therapy Dosage Variables vs Treatment Efficacy of Neuromusculoskeletal Conditions," 2020, Journal of Chiropractic Medicine
  • "Best Practices for Chiropractic Management of Patients with Chronic Musculoskeletal Pain: A Clinical Practice Guideline," 2020, The Journal of Alternative and Complementary Medicine
  • "The Role of Chiropractic Care in Providing Health Promotion and Clinical Preventive Services for Adult Patients with Musculoskeletal Pain: A Clinical Practice Guideline," 2021, The Journal of Alternative and Complementary Medicine
  • "The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron," 2022, Viruses
  • "What will travel medicine look like in the COVID-19 pandemic era?", 2020, Journal of Travel Medicine

Frequent collaborators in research include:

  • Cheryl Hawk
  • Wayne Whalen
  • Ronald J. Farabaugh
  • Clinton J. Daniels
  • Derek R. Anderson

Their publication record shows a sustained focus on clinical practice guidelines related to musculoskeletal pain, health promotion, as well as emerging issues in infectious diseases and travel medicine during the COVID-19 pandemic. The multidisciplinary nature of their research spans both clinical and public health dimensions.

Best Publications

  • The Epidemiology of Helicobacter pylori Infection

    David N. Taylor;Martin J. Blaser

  • EPIDEMIOLOGY OF CAMPYLOBACTER JEJUNI INFECTIONS

    Martin J. Blaser;David N. Taylor;Roger A. Feldman

  • Transcutaneous immunization: a human vaccine delivery strategy using a patch.

    Gregory M. Glenn;David N. Taylor;Xiuru Li;Sarah Frankel

  • A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children☆☆☆★

    Richard A. Oberhelman;Robert H. Gilman;Patricia Sheen;David N. Taylor

  • Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

    Christine B. Turley;Richard E. Rupp;Casey Johnson;David N. Taylor

  • Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

    Dani Cohen;Dani Cohen;Shai Ashkenazi;Shai Ashkenazi;Manfred S Green;Manfred S Green;Michael Gdalevich

  • Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

    Robert A. Kuschner;Andrew F. Trofa;Richard J. Thomas;Charles W. Hoge

  • Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report

    Mark S. Riddle;Bradley A. Connor;Nicholas J. Beeching;Herbert L. DuPont

  • ASTROVIRUSES AS A CAUSE OF GASTROENTERITIS IN CHILDREN

    J. E. Herrmann;D. N. Taylor;P. Echeverria;N. R. Blacklow

  • Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

    J. L. Sanchez;B. Vasquez;R. E. Begue;R. Meza

  • Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting.

    D N Taylor;I K Wachsmuth;Y H Shangkuan;E V Schmidt

  • Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

    D N Taylor;A C Trofa;J Sadoff;C Chu

  • Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously

    Fernando Güereña-Burgueño;Eric R. Hall;David N. Taylor;Frederick J. Cassels

  • Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)

    David N. Taylor;John J. Treanor;Cynthia Strout;Casey Johnson

  • Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

    John J. Treanor;David N. Taylor;Lynda Tussey;Christine Hay

  • Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype

    K.P. Killeen;D.T. Beattie;D.R. Spriggs;M.K. Waldor

  • A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF RIFAXIMIN COMPARED WITH PLACEBO AND WITH CIPROFLOXACIN IN THE TREATMENT OF TRAVELERS’ DIARRHEA

    David N Taylor;A Louis Bourgeois;Charles D Ericsson;Robert Steffen

  • Etiology of diarrhea among travelers and foreign residents in Nepal.

    David N. Taylor;Robin Houston;David R. Shlim;Manoon Bhaibulaya

  • Treatment of traveler's diarrhea with ciprofloxacin and loperamide.

    Bruno P. Petruccelli;Gerald S. Murphy;Jose L. Sanchez;Stephen Walz

  • Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.

    David N. Taylor;John J. Treanor;Eric A. Sheldon;Casey Johnson

  • Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial.

    David N. Taylor;Jose L. Sanchez;William Candler;Scott Thornton

Frequent Co-Authors

Peter Echeverria
Peter Echeverria University of Massachusetts Chan Medical School
Jerald C. Sadoff
Jerald C. Sadoff Janssen (Belgium)
Herbert L. DuPont
Herbert L. DuPont The University of Texas Health Science Center at Houston
Robert H. Gilman
Robert H. Gilman Johns Hopkins University
Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Steven S. Wasserman
Steven S. Wasserman University of Virginia
Neil R. Blacklow
Neil R. Blacklow University of Massachusetts Chan Medical School
John J. Mekalanos
John J. Mekalanos Harvard Medical School
James B. Kaper
James B. Kaper University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various career options, including roles outside traditional laboratory settings. For individuals seeking flexible education options, online degrees for felons can provide valuable opportunities to advance their careers and rebuild professional paths.

Health-related fields offer promising career trajectories, such as becoming a functional medicine nurse practitioner programs graduate. These programs blend conventional and alternative medical practices, providing holistic patient care skills highly valued in today's healthcare environment.

For those interested in the intersection of healthcare and information management, certification programs like the certified professional coder (cpc) can offer specialized training in medical coding and billing, essential for efficient healthcare administration.

Additionally, pursuing a degree in health information management can lead to rewarding careers with competitive pay. Learn more about the health information management degree salary and career pathways to understand the potential benefits and responsibilities of this field.

Best Scientists Citing David N. Taylor

Trending Scientists

Recently Published Articles